NRSA Training Core

项目摘要：威斯康星大学(UW)临床研究研究生项目(GPCI)是 由威斯康星大学临床和翻译研究所(卢旺达问题国际法庭)开发，并继续实施 由卢旺达问题国际法庭劳动力发展小组提供。GPCI为受训人员提供了多种教育选择 翻译研究连续体，但所有都基于一个共同的教学基础，包括 生物统计学、流行病学、临床研究设计、临床试验实施，以及道德和负责任的行为 研究的成果。这些基本课程要素由临床基础证书共享 研究，临床研究硕士和两个博士项目。临床研究博士学位是 学员专注于创建新的翻译方法和工具的应用型学位 在特定生物医学学科的背景下的科学。临床与转化学博士 利用核心课程为学员提供必要的技能和工具来推动他们的生物医学研究 沿着翻译的路径。自2008年成立以来，GPCI为以下方面创建了强大的基础设施 培训翻译劳动力的未来成员，使该项目的学生能够积累 令人印象深刻的出版物和研究奖项的记录。对于这一NRSA应用程序，新的领导层 被任命为不同于亲代UL1的人。David Demets博士和Elizabeth Meyerand博士都拥有 优秀的各级学员培训记录，是翻译行业的模范调查员 科学。具体目标包括维持现有的、高绩效的博士课程；应用 项目持续改进和纵向结果跟踪的综合评估方法；以及 制定招聘战略，以促进学员的多样性和成功。此外，一位新的博士后 将为拥有专业学位(MD、DVM、PharmD、Nursing)的个人创建培训计划，以 增强他们先前研究的翻译潜力，并提供通向未来独立职业生涯的桥梁 翻译科学。所有受训人员都将受益于现有的全面指导方法， 制定个性化职业发展计划(ICDP)和综合方案活动，包括 联邦授权的培训(HIPAA、花旗、GCP、RCR等)以及团队科学、科学和技术方面的额外培训 领导力、导师与被辅导者的关系，以及撰写手稿和助学金。GPCI还提供了职业生涯 创新和创业方面的发展研讨会和讲习班。扩展后的计划将支持 所有博士后和博士后类别的15项为期两年的任用合计。

Project Summary: The University of Wisconsin (UW) Graduate Program in Clinical Investigation (GPCI) was developed by the UW Institute for Clinical and Translational Research (ICTR) and continues to be administered by the ICTR Workforce Development group. GPCI houses multiple educational options for trainees in the translational research continuum, but all are based on a common didactic foundation encompassing biostatistics, epidemiology, clinical study design, clinical trials conduct, and the ethical and responsible conduct of research. These essential curriculum elements are shared by the Certificate in the Fundamentals of Clinical Research, the MS in Clinical Investigation, and two PhD programs. The PhD in Clinical Investigation is an applied degree in which trainees focus on the creation of novel methodologies and tools for translational science within the context of a specific biomedical discipline. The PhD in Clinical and Translational Science leverages the core curriculum to give trainees the skills and tools necessary to move their biomedical research along the translational pathway. Since its inception in 2008, GPCI has created a robust infrastructure for training future members of the translational workforce that has allowed students in the program to accumulate an impressive record of publications and research awards. For this NRSA application, new leadership has been appointed distinct from the parental UL1. David DeMets, PhD, and Elizabeth Meyerand, PhD, both have outstanding training records with mentees at all levels and are exemplary investigators in translational sciences. Specific aims include maintaining both existing, high-performing PhD programs; applying an integrated evaluation approach for continuous program improvement and longitudinal outcomes tracking; and developing recruitment strategies to foster trainee diversity and success. In addition, a new postdoctoral training program will be created for individuals with professional degrees (MD, DVM, PharmD, Nursing) to enhance the translational potential of their prior research and provide a bridge to future independent careers in translational sciences. All trainees will benefit from the existing comprehensive mentoring approach, development of individualized career development plans (ICDP), and integrated program activities including federally-mandated training (HIPAA, CITI, GCP, RCR, etc.) and additional training in team science, scientific leadership, mentor-mentee relationships, and writing manuscripts and grants. GPCI also provides career development seminars and workshops in innovation and entrepreneurship. The expanded program will support 15 two-year appointments combined in all pre and postdoctoral categories.